GENNEX LABORATORIES LTD.

Company Profile

GENNEX LABORATORIES LTD. had its IPO on under the ticker symbol GENNEX.

The company operates in the sector and industry. GENNEX LABORATORIES LTD. has a staff strength of 0 employees.

Stock update

Shares of GENNEX LABORATORIES LTD. opened at ₹7.97 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹7.6 - ₹8.03, and closed at ₹7.82.

This is a -1.88% slip from the previous day's closing price.

A total volume of 292,118 shares were traded at the close of the day’s session.

In the last one week, shares of GENNEX LABORATORIES LTD. have slipped by -2.49%.

GENNEX LABORATORIES LTD.'s Key Ratios

GENNEX LABORATORIES LTD. has a market cap of ₹1.08 billion, indicating a price to book ratio of 2.0682 and a price to sales ratio of 1.1772.

In the last 12-months GENNEX LABORATORIES LTD.’s revenue was ₹0 with a gross profit of ₹222.67 million and an EBITDA of ₹0. The EBITDA ratio measures GENNEX LABORATORIES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, GENNEX LABORATORIES LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 792.62%.

In Q1, GENNEX LABORATORIES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

GENNEX LABORATORIES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

75.8407

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into GENNEX LABORATORIES LTD.’s profitability.

GENNEX LABORATORIES LTD. stock is trading at a EV to sales ratio of 1.6238 and a EV to EBITDA ratio of 17.5199. Its price to sales ratio in the trailing 12-months stood at 1.1772.

GENNEX LABORATORIES LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.32 billion

Total Liabilities

₹295.13 million

Operating Cash Flow

₹-383734000.00

Capital Expenditure

₹397.86 million

Dividend Payout Ratio

0%

GENNEX LABORATORIES LTD. ended 2024 with ₹1.32 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.32 billion while shareholder equity stood at ₹803.50 million.

GENNEX LABORATORIES LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹295.13 million in other current liabilities, 180193000.00 in common stock, ₹623.31 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹145.01 million and cash and short-term investments were ₹150.64 million. The company’s total short-term debt was ₹10,536,000 while long-term debt stood at ₹162.88 million.

GENNEX LABORATORIES LTD.’s total current assets stands at ₹486.83 million while long-term investments were ₹0 and short-term investments were ₹145.01 million. Its net receivables were ₹94.17 million compared to accounts payable of ₹244.68 million and inventory worth ₹156.93 million.

In 2024, GENNEX LABORATORIES LTD.'s operating cash flow was ₹-383734000.00 while its capital expenditure stood at ₹397.86 million.

Comparatively, GENNEX LABORATORIES LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹7.82

52-Week High

₹9.2

52-Week Low

₹4.81

Analyst Target Price

₹

GENNEX LABORATORIES LTD. stock is currently trading at ₹7.82 per share. It touched a 52-week high of ₹9.2 and a 52-week low of ₹9.2. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹7.62 and 200-day moving average was ₹6.53 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.